Log in

Relevant bibliographies by topics / Prostate cancer survival / Books

To see the other types of publications on this topic, follow the link: Prostate cancer survival.

Books on the topic 'Prostate cancer survival'

Author: Grafiati

Published: 4 June 2021

Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 35 books for your research on the topic 'Prostate cancer survival.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

C, Nash Seymour, ed. Prostate cancer: Making survival decisions. University of Chicago Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Prostate cancer: My story of survival. The Pebble Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Marks, Sheldon. Prostate & cancer: A family guide to diagnosis, treatment & survival. 4th ed. Da Capo Life Long, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Prostate & cancer: A family guide to diagnosis, treatment & survival. 3rd ed. Perseus Pub., 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Marks, Sheldon. Prostate & cancer: A family guide to diagnosis, treatment & survival. Fisher Books, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Prostate & cancer: A family guide to diagnosis, treatment & survival. Fisher Books, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kim, Daniel Jae. A study of premorbid diet and prostate cancer survival. National Library of Canada, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Marks, Sheldon. Prostate & cancer: A family guide to diagnosis, treatment & survival. 3rd ed. Perseus Publishing, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Meridith, Alan T. Handbook of prostate cancer cell research: Growth, signalling, and survival. Nova Biomedical Books, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Handbook of prostate cancer cell research: Growth, signalling, and survival. Nova Biomedical Books, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

My angels are come: A deeply personal journal of cancer survival. Clumsy Ducks Pub., 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Aldrich, Tim E. Prostate cancer survival in North Carolina: Evaluating the race-specific differences. State Center for Health and Environmental Statistics, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Aldrich, Tim E. Prostate cancer survival in North Carolina: Evaluating the race-specific differences. State Center for Health and Environmental Statistics, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Prostate cancer, armed & ready: A survival guide to diagnosis, treatment and recovery. Victory Bookworks, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

How I survived prostate cancer-- and so can you: A guide for diagnosing and treating prostate cancer. Health Education Literary Publishers, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Me too: A doctor survives prostate cancer. WRS Pub., 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Hallerman, Victoria. How we survived prostate cancer: What we did and what we should have done. Newmarket Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Leahy, Richard A. Prostate Cancer Survival Guide. FirstPublish, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Joniau, Steve, S. Van Bruwaene, J. Karnes, et al. High-risk prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0066.

Full text

Abstract:

In this chapter, patients with adverse tumour characteristics and a high risk of tumour progression are discussed. In the current era of PSA testing, the proportion of patients presenting with high-risk prostate cancer (PCa) is estimated between 10% and 20% with a 10-year cancer specific survival approaching 40% for those not receiving active local treatment. The prevalence of high-risk disease varies with community PSA use, and is higher in countries (e.g. 30% in the United Kingdom) with little PSA testing. Adequate staging with magnetic resonance imaging for tumour extension, computer tomogr

APA, Harvard, Vancouver, ISO, and other styles

20

Marks, Sheldon Md. Prostate & Cancer: A Family Guide to Diagnosis, Treatment & Survival. 3rd ed. Fisher Books, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Prostate & Cancer: A Family Guide to Diagnosis, Treatment & Survival. Perseus Books Group, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Clarke, Noel W. Metastatic disease in prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0068.

Full text

Abstract:

Metastases are the predominant cause of morbidity and death from prostate cancer (CaP). The tendency for cells to migrate from the primary site, enter the vascular/lymphatic circulation, and implant/grow at secondary sites is the principal discriminator of aggressive form indolent disease. But this process is poorly understood. Cells enter the circulation in increasing number as the disease progresses, impinging on endothelial surfaces, particularly in red bone marrow where they bind and transmigrate, forming early cell colonies. This requires chemo-attractants and nutrients enabling cellular

APA, Harvard, Vancouver, ISO, and other styles

23

T, Meridith Alan, ed. Handbook of prostate cancer cell research: Growth, signalling, and survival. Nova Science, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Jemal, Ahmedin, D. Maxwell Parkin, and Freddie Bray. Patterns of Cancer Incidence, Mortality, and Survival. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0008.

Full text

Abstract:

The global burden of cancer is expected to increase from 14.1 million newly diagnosed cases and 8.2 million cancer deaths in 2012 to 22 million cases and 13 million deaths in 2030. This increase, based on projected population aging and growth, will disproportionately affect low- and middle-income countries (LMICs), where large numbers of young adults are now surviving to older ages where cancer becomes common. The incidence of cancers traditionally associated with Western behavioral, environmental, and cultural factors (breast, colorectum, lung, and prostate) are increasing in LMICs, whereas c

APA, Harvard, Vancouver, ISO, and other styles

25

Marks, Sheldon. Prostate And Cancer: A Family Guide To Diagnosis, Treatment And Survival (3rd Edition). 3rd ed. Perseus Books Group, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Breast Cancer and Prostate Cancer Avoidance & Survival Guide: Simple, natural, money-saving, and drug-free ways to avoid and even reverse two of the most dreaded cancers. PRI Publishing, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Mukherji, Deborah, Aurelius Omlin, Carmel Pezaro, and Johann De Bono. Novel therapies and emerging strategies for the treatment of patients with castration-resistant prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0069.

Full text

Abstract:

Castration-resistant prostate cancer (CRPC) represents a final stage of this malignancy for many men and is defined as the progression of prostate cancer despite castrate levels of testosterone. CRPC may present as a rising PSA, the development of new metastases, or worsening of known metastases. Recent advances have resulted in five new treatments for CRPC: the immunotherapy sipuleucel-T; the cytotoxic cabazitaxel; the androgen biosynthesis inhibitor abiraterone acetate; the radioisotope radium-223; and the antiandrogen enzalutamide. These have all improved overall survival in randomized phas

APA, Harvard, Vancouver, ISO, and other styles

28

Grant, Warren, and Martin Scott-Brown. Prevention of cancer. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0350.

Full text

Abstract:

In the UK, the four commonest cancers—lung cancer, breast cancer, colon cancer, and prostate cancer—result in around 62 000 deaths every year. Although deaths from cancer have fallen in the UK over the last 20 years, the UK still suffers from higher cancer death rates than many other countries in Western Europe. In 1999, the UK government produced a White Paper called Saving Lives: Our Healthier Nation that outlined a national target to reduce the death rate from cancer by at least 20% in people under 75 by 2010. The subsequent NHS Cancer Plan of 2000 designed a framework by which to achieve t

APA, Harvard, Vancouver, ISO, and other styles

29

Payne, James E. Me Too: A Doctor Survives Prostate Cancer. Wrs Pub, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Malik, Tariq M. Back Pain: It’s Not Always Arthritis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190271787.003.0029.

Full text

Abstract:

Back pain is prevalent in adults, and most often its cause is nonspecific and benign. Imaging and interventions are not always helpful and they are generally expensive and low yield. However, in about 10% or fewer cases, a specific etiology is found. A patient history, physical examination, and testing are the methods for finding the cause. Back pain from malignancy must also be considered. Prolonged survival from better chemotherapy has increased the incidence of metastases to bone, especially the spine. Common sources of spinal metastases are cancers of the prostate, kidneys, thyroid, breast

APA, Harvard, Vancouver, ISO, and other styles

31

Kobrin, Sarah C., and Alex Conway. Treatment for Early Stage Prostate Cancer. Edited by David A. Chambers, Wynne E. Norton, and Cynthia A. Vinson. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190647421.003.0017.

Full text

Abstract:

Men diagnosed with early stage prostate cancer will very likely survive many years after their prostate cancer treatment, regardless of which standard treatment is used. This case study describes a situation in which all standard treatments are supported by evidence but side effects vary greatly. In this situation, a partnership is needed between the doctor and the patient to choose the best option. This case study gives a brief overview of the complexities of choosing a treatment for early state prostate cancer and how implementation science is needed to (1) consider effectiveness and impleme

APA, Harvard, Vancouver, ISO, and other styles

32

susser, norman. At First You're Afraid: Lessons to be learned from a prostate cancer survivor. iUniverse, Inc., 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Sias, John. Will You (or Someone You Love) Get Prostate Cancer?: A Survivor Sheds Some Light. AuthorHouse, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

author, Solan Matthew, and Katz, Aaron, writer of forward, eds. Thrive don't only survive: Dr. Geo's guide to living your best life before & after prostate cancer : implement the science of the CaPLESS Method. 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Dave's Diary - One Man's Daily Account Of His Battle With Prostate Cancer And... How He Survived. Authorhouse, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!